Aperture Therapeutics

Private

San Carlos, CaliforniaHealthcare & Life Scienceshttps://www.aperturetx.com/

Last Round

Grant

Jun 15, 2026

Total Funding Raised

$1.09M

Company Overview

Aperture Therapeutics is a biotechnology company that develops oligonucleotide therapies for neurodegenerative diseases by leveraging human genetic resilience.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts

AI Layer

Application

Keywords

small molecule therapeuticsdrug discoveryprotein-protein interactionsbiotechundruggable targetspreclinical developmentdrug discovery platformsmall molecule inhibitorsai drug discoveryin silico drug designbiotech partneringtherapeutic pipelineNational Institute of Neurological Disorders and StrokeNINDSNIH

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Aperture Therapeutics Comps

Public and private peers based on sector, stage, and business model.

Aperture Therapeutics comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Aperture Therapeutics Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Grant	Jun 15, 2026
Accelerator	Apr 7, 2025
Grant	Jul 2, 2024

View all Funding Rounds

Key People

Founding team and executive leadership

Martin Jacko

Chief Executive Officer

Executive Team

Aperture Therapeutics Investors

Notable investors and investment history

Aperture Therapeutics investors
Investor	Rounds
LongGame Ventures	Seed
age1	Seed
National Institute of Neurological Disorders and Stroke (NINDS)	Grant
Ferocity Capital	Seed
Conscience VC	Seed
Ono Venture Investment, Inc.	Accelerator
Mission BioCapital	Seed, Accelerator

View all Investors

Aperture Therapeutics Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Aperture Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Aperture Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersSan Carlos, California

Employee Range7

Year Founded2022

Last FundingJun 15, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.